United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. for active treatment of motion sickness. for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. this drug should not be used in neonates or premature infants. because of the higher risk of antihistamines for infants

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. antihistaminic for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. motion sickness for active treatment of motion sickness. antiparkinsonism for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. use in neonates or premature infants this drug should not be used in neonates or prema

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. for active treatment of motion sickness. for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. this drug should not be used in neonates or premature infants. because of the higher risk of antihistamines for infants generally, and for neonates and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. because of the risk of local necrosis, this drug should not be used as a local anesthetic. hypersensitivity to diphenhydramine hydrochloride and other antihistamines of similar chemical structure.

United States - English - NLM (National Library of Medicine)

henry schein, inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride injection is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when the oral form is impractical: antihistaminic- for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. motion sickness- for active treatment of motion sickness. antiparkinsonism- for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows:  parkinsonism in the elderly who are unable to tolerate more potent agents, mild cases at parkinsonism in other age groups and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. use in neonates or premature infants this drug should not be used in neonates or premature infants. use in nursing mothers becaus

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. for active treatment of motion sickness. for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows:  parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. this drug should not be used in neonates or premature infants. because of the higher risk of antihista

Ireland - English - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - diphenhydramine hydrochloride, levomenthol - syrup - 7.0/0.55 mg/5ml - aminoalkyl ethers

Ireland - English - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - diphenhydramine hydrochloride, levomenthol - syrup - 14 / 1.1 mg/5ml - aminoalkyl ethers

Canada - English - Health Canada

fresenius kabi canada ltd - diphenhydramine hydrochloride - solution - 50mg - diphenhydramine hydrochloride 50mg - ethanolamine derivatives

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride in the oral form is effective for the following indications: for allergic conjunctivitis due to foods; mild, uncomplicated allergic skin manifestations of urticaria and angioedema; amelioration of allergic reactions to blood or plasma; dermatographism; as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. for active and prophylactic treatment of motion sickness. for parkinsonism (including drug-induced) in the elderly unable to tolerate more potent agents; mild cases of parkinsonism (including drug-induced) in other age groups; in other cases of parkinsonism (including drug-induced) in combination with centrally acting anticholinergic agents. nighttime sleep-aid. this drug should not be used in neonates or premature infants. because of the h

Kenya - English - Pharmacy and Poisons Board

orange pharma ltd baba dogo road near ruaraka police post after - promethazine hcl bp 2.5mg, diphenhydramine hcl bp… - syrup - promethazine hcl bp 2.5mg, diphenhydramine hcl bp… - promethazine